Lv6
1764 积分 2024-04-23 加入
Enhancing gastric cancer immunotherapy: Insights from multi-omics analysis and innovations in photodynamic-chemotherapy nanoplatforms
5天前
已关闭
Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant immunochemotherapy in gastric cancer
5天前
已完结
Comprehensive single-cell profiling uncovers TsMHC-II expression predicting response to neoadjuvant immunotherapy in gastric cancer
5天前
已关闭
Immune-featured stromal niches associate with response to neoadjuvant immunotherapy in oral squamous cell carcinoma
24天前
已完结
Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma
24天前
已完结
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
1个月前
已完结
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology
1个月前
已完结
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial
1个月前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
1个月前
已完结
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
1个月前
已完结
皖公网安备34019202002308
